AstraZeneca Pharmaceuticals LP
NEWS
It was a busy week for clinical trial announcements. Here’s a look.
For BioSpace’s recent Ideal Employer report, life sciences professionals weighed in on the topic.
The experimental drug, if approved, will compete with GlaxoSmithKline’s Benlysta, which is the only new drug approved for lupus in the last 60 years.
AstraZeneca is significantly expanding its footprint in China with the establishment of a global research and development center in the country, as well as the launch of a $1 billion fund aimed at supporting that nation’s healthcare sector.
The newly-launched index takes a focused look at the breadth and depth of novel agents currently being developed within the most innovative pharmaceutical pipelines.
Thanks to a new regulatory win, AstraZeneca’s Farxiga can now be used to reduce the risk of hospitalization for heart failure in type 2 diabetes patients with cardiovascular disease and with certain risk factors.
GlobalData recently published their top 20 global pharma companies categorized by market capitalization in the first quarter of 2019.
In the latest Ideal Employer Survey, BioSpace readers chimed in their thoughts on which companies across the biotech and biopharma industries were doing the most interesting and meaningful work.
It was another busy week for clinical trials. Here’s a look.
JOBS
IN THE PRESS